A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants
Status:
Completed
Trial end date:
2021-02-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence of a single dose of fezolinetant
test formulation compared to a single dose of fezolinetant reference formulation under
fasting conditions. This study will also evaluate the safety and tolerability of a single
dose of fezolinetant test formulation and a single dose of fezolinetant reference
formulation.